The Valley Desk

NCT01488929 · Interventional trial

Efficacy, Safety, and Tolerability of TC-5619 as Augmentation Therapy to Improve Negative Symptoms and Cognition in Outpatients With Schizophrenia

Overall registry status Completed

Phase 2

Conditions Cognitive Dysfunction, Negative Symptoms, Schizophrenia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov